Kenyan scientists are awaiting approval for clinical trials of three drugs in the treatment of Covid-19.

The researchers plan to conduct trials on Remdesivir, an anti-malaria drug originally developed as an Ebola treatment.

Kenya's lead investigator in the study LOICE ACHIENG OMBAJO is quoted as saying the trials is part of an international trial but did not mention who is sponsoring the study.

She said they are waiting for approvals from the Poisons and Pharmacies Board and the National Council of Science, Technology and Innovation.